Skip to content

Comparison investigation of the effect of Letrozole misoprostol to induce abortion in the second trimester of pregnancy

Comparison of misoprostol with letrozole and without letrozole to induce abortion in the second trimester of pregnancy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015123114333N48
Enrollment
120
Registered
2016-03-02
Start date
2016-01-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Termination of pregnancy in the second trimester. Medical abortion

Interventions

Intervention 1: In the experimental group letrozole tablets orally at a dose of 2 .5 mg in the form of two tablets given every 12 hours for two days. At the beginning of the third day Misoprostol tabl
Treatment - Drugs
In the experimental group letrozole tablets orally at a dose of 2 .5 mg in the form of two tablets given every 12 hours for two days. At the beginning of the third day Misoprostol tablets at a dose of
The control group will receive 8 placebo tablets on two consecutive days , 2 tablets every 12 hours given. Then on the third day, vaginal misoprostol of 100 micrograms as a 4 tablets every 6 hours wi

Sponsors

Vice chancellor for research, Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gestational age of 13 to 22 with an indication for termination of pregnancy in medical method; Chorioamionitic. Exclusion criteria: Patients with a history of caesarean section; Maternal serious chronic systemic and chronic disease; Cardiovascular disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of induction to abortion. Timepoint: From admission until 48 hours later. Method of measurement: Doctor observation.;Blood pressure. Timepoint: Baseline, every 2 hours, discharge time. Method of measurement: Manometer.;Heart rate. Timepoint: Baseline, every 2 hours, discharge time. Method of measurement: By doctor.;Temperature. Timepoint: Baseline, every 2 hours, discharge time. Method of measurement: By thermometer.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026